{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:43:00Z","timestamp":1791276180193,"version":"4.1.0"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2014,10,11]],"date-time":"2014-10-11T00:00:00Z","timestamp":1412985600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1007\/s00415-014-7520-7","type":"journal-article","created":{"date-parts":[[2014,10,23]],"date-time":"2014-10-23T22:21:27Z","timestamp":1414102887000},"page":"2234-2243","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Inherited disorders of the neuromuscular junction: an update"],"prefix":"10.1007","volume":"261","author":[{"given":"Pedro M.","family":"Rodr\u00edguez Cruz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Palace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Beeson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,10,11]]},"reference":[{"key":"7520_CR1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jneuroim.2008.05.030","volume":"201\u2013202","author":"J Palace","year":"2008","unstructured":"Palace J, Beeson D (2008) The congenital myasthenic syndromes. J Neuroimmunol 201\u2013202:2\u20135","journal-title":"J Neuroimmunol"},{"key":"7520_CR2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ajhg.2012.05.022","volume":"91","author":"K Belaya","year":"2012","unstructured":"Belaya K, Finlayson S, Slater CR et al (2012) Mutations in DPAGT1 cause a limb-girdle congenital myasthenic syndrome with tubular aggregates. Am J Hum Genet 91:193\u2013201","journal-title":"Am J Hum Genet"},{"key":"7520_CR3","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ajhg.2011.01.008","volume":"88","author":"J Senderek","year":"2011","unstructured":"Senderek J, M\u00fcller JS, Dusl M et al (2011) Hexosamine biosynthetic pathway mutations cause neuromuscular transmission defect. Am J Hum Genet 88:162\u2013172","journal-title":"Am J Hum Genet"},{"key":"7520_CR4","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1093\/brain\/awt010","volume":"136","author":"J Cossins","year":"2013","unstructured":"Cossins J, Belaya K, Hicks D et al (2013) Congenital myasthenic syndromes due to mutations in ALG2 and ALG14. Brain 136:944\u2013956","journal-title":"Brain"},{"key":"7520_CR5","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.nmd.2011.12.004","volume":"22","author":"A Chaouch","year":"2012","unstructured":"Chaouch A, Beeson D, Hanta\u00ef D, Lochm\u00fcller H (2012) 186th ENMC international workshop: congenital myasthenic syndromes 24\u201326 June 2011, Naarden, The Netherlands. Neuromuscul Disord 22:566\u2013576","journal-title":"Neuromuscul Disord"},{"key":"7520_CR6","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.nmd.2011.10.009","volume":"22","author":"AG Engel","year":"2012","unstructured":"Engel AG (2012) Current status of the congenital myasthenic syndromes. Neuromuscul Disord 22:99\u2013111","journal-title":"Neuromuscul Disord"},{"key":"7520_CR7","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1136\/practneurol-2012-000404","volume":"13","author":"S Finlayson","year":"2013","unstructured":"Finlayson S, Beeson D, Palace J (2013) Congenital myasthenic syndromes: an update. Pract Neurol 13:80\u201391","journal-title":"Pract Neurol"},{"key":"7520_CR8","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1093\/brain\/aws016","volume":"135","author":"R Webster","year":"2012","unstructured":"Webster R, Maxwell S, Spearman H et al (2012) A novel congenital myasthenic syndrome due to decreased acetylcholine receptor ion-channel conductance. Brain 135:1070\u20131080","journal-title":"Brain"},{"key":"7520_CR9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/hmg\/ddt397","volume":"23","author":"H Zhu","year":"2014","unstructured":"Zhu H, Pytel P, Gomez CM (2014) Selective inhibition of caspases in skeletal muscle reverses the apoptotic synaptic degeneration in slow-channel myasthenic syndrome. Hum Mol Genet 23:69\u201377","journal-title":"Hum Mol Genet"},{"key":"7520_CR10","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s00415-011-6204-9","volume":"259","author":"A Chaouch","year":"2012","unstructured":"Chaouch A, M\u00fcller JS, Guergueltcheva V et al (2012) A retrospective clinical study of the treatment of slow-channel congenital myasthenic syndrome. J Neurol 259:474\u2013481","journal-title":"J Neurol"},{"key":"7520_CR11","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.expneurol.2013.06.012","volume":"248","author":"RG Webster","year":"2013","unstructured":"Webster RG, Cossins J, Lashley D et al (2013) A mouse model of the slow channel myasthenic syndrome: Neuromuscular physiology and effects of ephedrine treatment. Exp Neurol 248:286\u2013298","journal-title":"Exp Neurol"},{"key":"7520_CR12","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.nmd.2011.08.002","volume":"22","author":"J Palace","year":"2012","unstructured":"Palace J, Lashley D, Bailey S et al (2012) Clinical features in a series of fast channel congenital myasthenia syndrome. Neuromuscul Disord 22:112\u2013117","journal-title":"Neuromuscul Disord"},{"key":"7520_CR13","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1212\/WNL.0b013e31825b5bda","volume":"79","author":"X-M Shen","year":"2012","unstructured":"Shen X-M, Brengman JM, Edvardson S et al (2012) Highly fatal fast-channel syndrome caused by AChR \u03b5 subunit mutation at the agonist binding site. Neurology 79:449\u2013454","journal-title":"Neurology"},{"key":"7520_CR14","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1172\/JCI63415","volume":"122","author":"X Shen","year":"2012","unstructured":"Shen X, Brengman JM, Sine SM, Engel AG (2012) Myasthenic syndrome AChR \u03b1 C-loop mutant disrupts initiation of channel gating. J Clin Invest 122:2613\u20132621","journal-title":"J Clin Invest"},{"key":"7520_CR15","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.nmd.2013.10.009","volume":"24","author":"R Webster","year":"2013","unstructured":"Webster R, Liu W-W, Chaouch A et al (2013) Fast-channel congenital myasthenic syndrome with a novel acetylcholine receptor mutation at the \u03b1-\u03b5 subunit interface. Neuromuscul Disord 24:143\u2013147","journal-title":"Neuromuscul Disord"},{"key":"7520_CR16","doi-asserted-by":"crossref","first-page":"4110","DOI":"10.1523\/JNEUROSCI.0025-07.2007","volume":"27","author":"N Mukhtasimova","year":"2007","unstructured":"Mukhtasimova N, Sine SM (2007) An intersubunit trigger of channel gating in the muscle nicotinic receptor. J Neurosci 27:4110\u20134119","journal-title":"J Neurosci"},{"key":"7520_CR17","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1038\/srep02931","volume":"3","author":"MA Rahman","year":"2013","unstructured":"Rahman MA, Masuda A, Ohe K et al (2013) HnRNP L and hnRNP LL antagonistically modulate PTB-mediated splicing suppression of CHRNA1 pre-mRNA. Sci Rep 3:2931","journal-title":"Sci Rep"},{"key":"7520_CR18","unstructured":"Park J, Mott M, Williams T, et al. (2014) Neurobiology of disease a single mutation in the acetylcholine receptor \u03b4-subunit causes distinct effects in two types of neuromuscular synapses. 34:10211\u201310218"},{"key":"7520_CR19","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1111\/j.1460-9568.2010.07569.x","volume":"33","author":"AR Punga","year":"2011","unstructured":"Punga AR, Maj M, Lin S et al (2011) MuSK levels differ between adult skeletal muscles and influence postsynaptic plasticity. Eur J Neurosci 33:890\u2013898","journal-title":"Eur J Neurosci"},{"key":"7520_CR20","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0092-8674(00)81251-9","volume":"85","author":"TM DeChiara","year":"1996","unstructured":"DeChiara TM, Bowen DC, Valenzuela DM et al (1996) The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivo. Cell 85:501\u2013512","journal-title":"Cell"},{"key":"7520_CR21","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1212\/WNL.0b013e3181c3fce9","volume":"73","author":"V Mihaylova","year":"2009","unstructured":"Mihaylova V, Salih MaM, Mukhtar MM et al (2009) Refinement of the clinical phenotype in musk-related congenital myasthenic syndromes. Neurology 73:1926\u20131928","journal-title":"Neurology"},{"key":"7520_CR22","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1051\/jbio:2005008","volume":"199","author":"F Chevessier","year":"2005","unstructured":"Chevessier F, Faraut B, Ravel-Chapuis A et al (2005) Pathophysiological characterization of congenital myasthenic syndromes: the example of mutations in the MUSK gene. J Soc Biol 199:61\u201377","journal-title":"J Soc Biol"},{"key":"7520_CR23","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1093\/hmg\/ddq110","volume":"19","author":"Ra Maselli","year":"2010","unstructured":"Maselli Ra, Arredondo J, Cagney O et al (2010) Mutations in MUSK causing congenital myasthenic syndrome impair MuSK-Dok-7 interaction. Hum Mol Genet 19:2370\u20132379","journal-title":"Hum Mol Genet"},{"key":"7520_CR24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.nmd.2013.08.002","volume":"24","author":"C Gallenm\u00fcller","year":"2014","unstructured":"Gallenm\u00fcller C, Felber WM, Dusl M et al (2014) Salbutamol-responsive limb-girdle congenital myasthenic syndrome due to a novel missense mutation and heteroallelic deletion in MUSK. Neuromuscul Disord 24:31\u201335","journal-title":"Neuromuscul Disord"},{"key":"7520_CR25","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1126\/science.1127142","volume":"312","author":"K Okada","year":"2006","unstructured":"Okada K, Inoue A, Okada M et al (2006) The muscle protein Dok-7 is essential for neuromuscular synaptogenesis. Science 312:1802\u20131805","journal-title":"Science"},{"key":"7520_CR26","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1126\/science.1130837","volume":"313","author":"D Beeson","year":"2006","unstructured":"Beeson D, Higuchi O, Palace J et al (2006) Dok-7 mutations underlie a neuromuscular junction synaptopathy. Science 313:1975\u20131978","journal-title":"Science"},{"key":"7520_CR27","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.nmd.2013.06.002","volume":"23","author":"A Klein","year":"2013","unstructured":"Klein A, Pitt MC, McHugh JC et al (2013) DOK7 congenital myasthenic syndrome in childhood: early diagnostic clues in 23 children. Neuromuscul Disord 23:883\u2013891","journal-title":"Neuromuscul Disord"},{"key":"7520_CR28","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1093\/hmg\/dds198","volume":"21","author":"J Cossins","year":"2012","unstructured":"Cossins J, Liu WW, Belaya K et al (2012) The spectrum of mutations that underlie the neuromuscular junction synaptopathy in DOK7 congenital myasthenic syndrome. Hum Mol Genet 21:3765\u20133775","journal-title":"Hum Mol Genet"},{"key":"7520_CR29","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1001\/jamaneurol.2013.5590","volume":"71","author":"N Witting","year":"2014","unstructured":"Witting N, Vissing J (2014) Pharmacologic treatment of downstream of tyrosine kinase 7 congenital myasthenic syndrome. JAMA Neurol 71:350\u2013354","journal-title":"JAMA Neurol"},{"key":"7520_CR30","doi-asserted-by":"crossref","first-page":"9654","DOI":"10.1073\/pnas.95.16.9654","volume":"95","author":"K Ohno","year":"1998","unstructured":"Ohno K, Brengman J, Tsujino a, Engel aG (1998) Human endplate acetylcholinesterase deficiency caused by mutations in the collagen-like tail subunit (ColQ) of the asymmetric enzyme. Proc Natl Acad Sci USA 95:9654\u20139659","journal-title":"Proc Natl Acad Sci USA"},{"key":"7520_CR31","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1038\/mt.2012.34","volume":"20","author":"M Ito","year":"2012","unstructured":"Ito M, Suzuki Y, Okada T et al (2012) Protein-anchoring strategy for delivering acetylcholinesterase to the neuromuscular junction. Mol Ther 20:1384\u20131392","journal-title":"Mol Ther"},{"key":"7520_CR32","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/humu.22325","volume":"34","author":"T Nakata","year":"2013","unstructured":"Nakata T, Ito M, Azuma Y et al (2013) Mutations in the C-terminal domain of ColQ in endplate acetylcholinesterase deficiency compromise ColQ-MuSK interaction. Hum Mutat 34:997\u20131004","journal-title":"Hum Mutat"},{"key":"7520_CR33","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00439-013-1391-3","volume":"133","author":"J Arredondo","year":"2013","unstructured":"Arredondo J, Lara M, Ng F et al (2013) COOH-terminal collagen Q (COLQ) mutants causing human deficiency of endplate acetylcholinesterase impair the interaction of ColQ with proteins of the basal lamina. Hum Genet 133:599\u2013616","journal-title":"Hum Genet"},{"key":"7520_CR34","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.pediatrneurol.2014.03.012","volume":"51","author":"HN Matlik","year":"2014","unstructured":"Matlik HN, Milhem RM, Saadeldin IY et al (2014) Clinical and molecular analysis of a novel COLQ missense mutation causing congenital myasthenic syndrome in a Syrian family. Pediatr Neurol 51:165\u2013169","journal-title":"Pediatr Neurol"},{"key":"7520_CR35","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1073\/pnas.98.4.2017","volume":"98","author":"K Ohno","year":"2001","unstructured":"Ohno K, Tsujino a, Brengman JM et al (2001) Choline acetyltransferase mutations cause myasthenic syndrome associated with episodic apnea in humans. Proc Natl Acad Sci USA 98:2017\u20132022","journal-title":"Proc Natl Acad Sci USA"},{"key":"7520_CR36","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ejpn.2009.09.009","volume":"14","author":"U Schara","year":"2010","unstructured":"Schara U, Christen H-J, Durmus H et al (2010) Long-term follow-up in patients with congenital myasthenic syndrome due to CHAT mutations. Eur J Paediatr Neurol 14:326\u2013333","journal-title":"Eur J Paediatr Neurol"},{"key":"7520_CR37","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1002\/humu.21560","volume":"32","author":"X-M Shen","year":"2011","unstructured":"Shen X-M, Crawford TO, Brengman J et al (2011) Functional consequences and structural interpretation of mutations of human choline acetyltransferase. Hum Mutat 32:1259\u20131267","journal-title":"Hum Mutat"},{"key":"7520_CR38","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.cell.2008.10.002","volume":"135","author":"N Kim","year":"2008","unstructured":"Kim N, Stiegler AL, Cameron TO et al (2008) Lrp4 is a receptor for Agrin and forms a complex with MuSK. Cell 135:334\u2013342","journal-title":"Cell"},{"key":"7520_CR39","doi-asserted-by":"crossref","first-page":"40624","DOI":"10.1074\/jbc.M111.279307","volume":"286","author":"W Zhang","year":"2011","unstructured":"Zhang W, Coldefy A-S, Hubbard SR, Burden SJ (2011) Agrin binds to the N-terminal region of Lrp4 protein and stimulates association between Lrp4 and the first immunoglobulin-like domain in muscle-specific kinase (MuSK). J Biol Chem 286:40624\u201340630","journal-title":"J Biol Chem"},{"key":"7520_CR40","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1093\/hmg\/ddt578","volume":"23","author":"B Ohkawara","year":"2013","unstructured":"Ohkawara B, Cabrera-Serrano M, Nakata T et al (2013) LRP4 third \u03b2-propeller domain mutations cause novel congenital myasthenia by compromising agrin-mediated musk signaling in a position-specific manner. Hum Mol Genet 23:1856\u20131868","journal-title":"Hum Mol Genet"},{"key":"7520_CR41","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ajhg.2009.06.015","volume":"85","author":"P Richard","year":"2009","unstructured":"Richard P, Goillot E, Huze C et al (2009) Identification of an agrin mutation that causes congenital myasthenia and affects synapse function. Am J Hum Genet 85:155\u2013167","journal-title":"Am J Hum Genet"},{"key":"7520_CR42","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s00439-011-1132-4","volume":"131","author":"RA Maselli","year":"2012","unstructured":"Maselli RA, Fernandez JM, Arredondo J et al (2012) LG2 agrin mutation causing severe congenital myasthenic syndrome mimics functional characteristics of non-neural (z-) agrin. Hum Genet 131:1123\u20131135","journal-title":"Hum Genet"},{"key":"7520_CR43","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1093\/brain\/awu160","volume":"137","author":"S Nicole","year":"2014","unstructured":"Nicole S, Chaouch A, Torbergsen T et al (2014) Agrin mutations lead to a congenital myasthenic syndrome with distal muscle weakness and atrophy. Brain 137:2429\u20132443","journal-title":"Brain"},{"key":"7520_CR44","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1208\/s12248-010-9208-y","volume":"12","author":"AM Lone","year":"2010","unstructured":"Lone AM, Nolte WM, Tinoco AD, Saghatelian A (2010) Peptidomics of the prolyl peptidases. AAPS J 12:483\u2013491","journal-title":"AAPS J"},{"key":"7520_CR45","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1515\/BC.2006.111","volume":"387","author":"K Martens","year":"2006","unstructured":"Martens K, Derua R, Meulemans S et al (2006) PREPL: a putative novel oligopeptidase propelled into the limelight. Biol Chem 387:879\u2013883","journal-title":"Biol Chem"},{"key":"7520_CR46","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1212\/WNL.0000000000000295","volume":"82","author":"L R\u00e9gal","year":"2014","unstructured":"R\u00e9gal L, Shen X-M, Selcen D et al (2014) PREPL deficiency with or without cystinuria causes a novel myasthenic syndrome. Neurology 82:1254\u20131260","journal-title":"Neurology"},{"key":"7520_CR47","doi-asserted-by":"crossref","first-page":"12580","DOI":"10.1074\/jbc.M310681200","volume":"279","author":"M-H Kim","year":"2004","unstructured":"Kim M-H, Hersh LB (2004) The vesicular acetylcholine transporter interacts with clathrin-associated adaptor complexes AP-1 and AP-2. J Biol Chem 279:12580\u201312587","journal-title":"J Biol Chem"},{"key":"7520_CR48","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1242\/jcs.116079","volume":"126","author":"K Radhakrishnan","year":"2013","unstructured":"Radhakrishnan K, Baltes J, Creemers JWM, Schu P (2013) Trans-Golgi network morphology and sorting is regulated by prolyl-oligopeptidase-like protein PREPL and the AP-1 complex subunit \u03bc1A. J Cell Sci 126:1155\u20131163","journal-title":"J Cell Sci"},{"key":"7520_CR49","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1146\/annurev.genom.2.1.129","volume":"2","author":"J Jaeken","year":"2001","unstructured":"Jaeken J, Matthijs G (2001) Congenital disorders of glycosylation. Annu Rev Genomics Hum Genet 2:129\u2013151","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"7520_CR50","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/humu.10239","volume":"22","author":"X Wu","year":"2003","unstructured":"Wu X, Rush JS, Karaoglu D et al (2003) Deficiency of UDP-GlcNAc:Dolichol Phosphate N-Acetylglucosamine-1 Phosphate Transferase (DPAGT1) causes a novel congenital disorder of Glycosylation Type I. J Hum Mutat 22:144\u2013150","journal-title":"J Hum Mutat"},{"key":"7520_CR51","doi-asserted-by":"crossref","first-page":"22498","DOI":"10.1074\/jbc.M302850200","volume":"278","author":"C Thiel","year":"2003","unstructured":"Thiel C, Schwarz M, Peng J et al (2003) A new type of congenital disorders of glycosylation (CDG-Ii) provides new insights into the early steps of dolichol-linked oligosaccharide biosynthesis. J Biol Chem 278:22498\u201322505","journal-title":"J Biol Chem"},{"key":"7520_CR52","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1146\/annurev.biochem.73.011303.074043","volume":"73","author":"RS Haltiwanger","year":"2004","unstructured":"Haltiwanger RS, Lowe JB (2004) Role of glycosylation in development. Annu Rev Biochem 73:491\u2013537","journal-title":"Annu Rev Biochem"},{"key":"7520_CR53","unstructured":"Velina Guergueltcheva, Jacqueline Palace, David Beeson HL (2011) Congenital myasthenic syndrome with tubular aggregates caused by GFPT1 mutations. J Neurol"},{"key":"7520_CR54","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1212\/WNL.0b013e31829c5e9c","volume":"81","author":"D Selcen","year":"2013","unstructured":"Selcen D, Shen X-M, Milone M et al (2013) GFPT1-myasthenia: clinical, structural, and electrophysiologic heterogeneity. Neurology 81:370\u2013378","journal-title":"Neurology"},{"key":"7520_CR55","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/mus.23451","volume":"46","author":"S-Y Huh","year":"2012","unstructured":"Huh S-Y, Kim H-S, Jang H-J et al (2012) Limb-girdle myasthenia with tubular aggregates associated with novel GFPT1 mutations. Muscle Nerve 46:600\u2013604","journal-title":"Muscle Nerve"},{"key":"7520_CR56","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1023\/B:NEUR.0000020632.41508.83","volume":"32","author":"PT Martin","year":"2003","unstructured":"Martin PT (2003) Glycobiology of the neuromuscular junction. J Neurocytol 32:915\u2013929","journal-title":"J Neurocytol"},{"key":"7520_CR57","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1093\/hmg\/ddt145","volume":"22","author":"K Zoltowska","year":"2013","unstructured":"Zoltowska K, Webster R, Finlayson S et al (2013) Mutations in GFPT1 that underlie limb-girdle congenital myasthenic syndrome result in reduced cell-surface expression of muscle AChR. Hum Mol Genet 22:2905\u20132913","journal-title":"Hum Mol Genet"},{"key":"7520_CR58","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2174\/138945009788488369","volume":"10","author":"RK Bretthauer","year":"2009","unstructured":"Bretthauer RK (2009) Structure, expression, and regulation of UDP-GlcNAc: dolichol phosphate GlcNAc-1-phosphate transferase (DPAGT1). Curr Drug Targets 10:477\u2013482","journal-title":"Curr Drug Targets"},{"key":"7520_CR59","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1016\/S0021-9258(18)34979-2","volume":"257","author":"JP Merlie","year":"1982","unstructured":"Merlie JP, Sebbane R, Tzartos S, Lindstrom J (1982) Inhibition of glycosylation with tunicamycin blocks assembly of newly synthesized acetylcholine receptor subunits in muscle cells. J Biol Chem 257:2694\u20132701","journal-title":"J Biol Chem"},{"key":"7520_CR60","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1212\/WNL.0000000000000435","volume":"82","author":"D Selcen","year":"2014","unstructured":"Selcen D, Shen X, Brengman J (2014) expression studies DPAGT1 myasthenia and myopathy. Neurology 82:1822\u20131830","journal-title":"Neurology"},{"key":"7520_CR61","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.nmd.2013.03.003","volume":"23","author":"K Basiri","year":"2013","unstructured":"Basiri K, Belaya K, Liu WW et al (2013) Clinical features in a large Iranian family with a limb-girdle congenital myasthenic syndrome due to a mutation in DPAGT1. Neuromuscul Disord 23:469\u2013472","journal-title":"Neuromuscul Disord"},{"key":"7520_CR62","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/glycob\/3.4.357","volume":"3","author":"BJ Jackson","year":"1993","unstructured":"Jackson BJ, Kukuruzinska MA, Robbins P (1993) Biosynthesis of asparagine-linked oligosaccharides in Saccharomyces cerevisiae: the alg2 mutation. Glycobiology 3:357\u2013364","journal-title":"Glycobiology"},{"key":"7520_CR63","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/glycob\/cwr162","volume":"22","author":"J Lu","year":"2012","unstructured":"Lu J, Takahashi T, Ohoka A et al (2012) Alg14 organizes the formation of a multiglycosyltransferase complex involved in initiation of lipid-linked oligosaccharide biosynthesis. Glycobiology 22:504\u2013516","journal-title":"Glycobiology"},{"key":"7520_CR64","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.nmd.2013.12.010","volume":"24","author":"DM Monies","year":"2014","unstructured":"Monies DM, Al-Hindi HN, Al-Muhaizea Ma et al (2014) Clinical and pathological heterogeneity of a congenital disorder of glycosylation manifesting as a myasthenic\/myopathic syndrome. Neuromuscul Disord 24:353\u2013359","journal-title":"Neuromuscul Disord"},{"key":"7520_CR65","author":"P Rodriguez Cruz","year":"2014","unstructured":"Rodriguez Cruz P, Sewry C, Beeson D et al (2014) Science direct congenital myopathies with secondary neuromuscular transmission defects.A case report and review of the literature. Neuromuscul Disord. doi: 10.1016\/j.nmd.2014.07.005","journal-title":"Neuromuscul Disord"},{"key":"7520_CR66","unstructured":"Illingworth M, Main M, Pitt M, et al. RYR1-related congenital myopathy with fatigable weakness, responding to pyridostigimine"},{"key":"7520_CR67","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.nmd.2010.07.274","volume":"20","author":"P Munot","year":"2010","unstructured":"Munot P, Lashley D, Jungbluth H et al (2010) Congenital fibre type disproportion associated with mutations in the tropomyosin 3 (TPM3) gene mimicking congenital myasthenia. Neuromuscul Disord 20:796\u2013800","journal-title":"Neuromuscul Disord"},{"key":"7520_CR68","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.nmd.2011.02.012","volume":"21","author":"Sa Robb","year":"2011","unstructured":"Robb Sa, Sewry Ca, Dowling JJ et al (2011) Impaired neuromuscular transmission and response to acetylcholinesterase inhibitors in centronuclear myopathies. Neuromuscul Disord 21:379\u2013386","journal-title":"Neuromuscul Disord"},{"key":"7520_CR69","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.nmd.2011.03.002","volume":"21","author":"T Liewluck","year":"2012","unstructured":"Liewluck T, Shen X-M, Milone M, Engel AG (2012) Endplate structure and parameters of neuromuscular transmission in sporadic centronuclear myopathy associated with myasthenia. Neuromuscul Disord 21:387\u2013395","journal-title":"Neuromuscul Disord"},{"key":"7520_CR70","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00109-013-0994-4","volume":"91","author":"EM Gibbs","year":"2013","unstructured":"Gibbs EM, Clarke NF, Rose K et al (2013) Neuromuscular junction abnormalities in DNM2-related centronuclear myopathy. J Mol Med (Berl) 91:727\u2013737","journal-title":"J Mol Med (Berl)"},{"key":"7520_CR71","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s00415-012-6709-x","volume":"260","author":"L Servais","year":"2013","unstructured":"Servais L, Baudoin H, Zehrouni K et al (2013) Pregnancy in congenital myasthenic syndrome. J Neurol 260:815\u2013819","journal-title":"J Neurol"},{"key":"7520_CR72","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jns.2013.05.017","volume":"331","author":"PJ Lorenzoni","year":"2013","unstructured":"Lorenzoni PJ, Scola RH, Kay CSK et al (2013) Salbutamol therapy in congenital myasthenic syndrome due to DOK7 mutation. J Neurol Sci 331:155\u2013157","journal-title":"J Neurol Sci"},{"key":"7520_CR73","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.nmd.2012.11.004","volume":"23","author":"G Burke","year":"2013","unstructured":"Burke G, Hiscock A, Klein A et al (2013) Salbutamol benefits children with congenital myasthenic syndrome due to DOK7 mutations. Neuromuscul Disord 23:170\u2013175","journal-title":"Neuromuscul Disord"},{"key":"7520_CR74","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1212\/WNL.0b013e3181dd43bf","volume":"74","author":"D Lashley","year":"2010","unstructured":"Lashley D, Palace J, Jayawant S et al (2010) Ephedrine treatment in congenital myasthenic syndrome due to mutations in DOK7. Neurology 74:1517\u20131523","journal-title":"Neurology"},{"key":"7520_CR75","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/mus.22153","volume":"44","author":"M Sadeh","year":"2012","unstructured":"Sadeh M, Xin-Ming SEA (2012) Beneficial effect of albuterol in CMS with epsilon subunit mutations. Muscle Nerve 44:289\u2013291","journal-title":"Muscle Nerve"},{"key":"7520_CR76","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1136\/jnnp-2012-304716","volume":"84","author":"S Finlayson","year":"2013","unstructured":"Finlayson S, Palace J, Belaya K et al (2013) Clinical features of congenital myasthenic syndrome due to mutations in DPAGT1. J Neurol Neurosurg Psychiatry 84:1119\u20131125","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"7520_CR77","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/mus.22176","volume":"44","author":"T Liewluck","year":"2011","unstructured":"Liewluck T, Selcen D, Engel AG (2011) Beneficial effects of Albuterol in congenital endplate acetylcholinesterase deficiency and DOK-7 myasthenia. Muscle Nerve 44:789\u2013794","journal-title":"Muscle Nerve"},{"key":"7520_CR78","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.nmd.2011.09.002","volume":"22","author":"I Wargon","year":"2012","unstructured":"Wargon I, Richard P, Kuntzer T et al (2012) Long-term follow-up of patients with congenital myasthenic syndrome caused by COLQ mutations. Neuromuscul Disord 22:318\u2013324","journal-title":"Neuromuscul Disord"},{"key":"7520_CR79","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/brain\/awm325","volume":"131","author":"V Mihaylova","year":"2008","unstructured":"Mihaylova V, M\u00fcller JS, Vilchez JJ et al (2008) Clinical and molecular genetic findings in COLQ-mutant congenital myasthenic syndromes. Brain 131:747\u2013759","journal-title":"Brain"},{"key":"7520_CR80","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.pediatrneurol.2012.02.003","volume":"46","author":"A Guven","year":"2012","unstructured":"Guven A, Demirci M, Anlar B (2012) Recurrent COLQ mutation in congenital myasthenic syndrome. Pediatr Neurol 46:253\u2013256","journal-title":"Pediatr Neurol"},{"key":"7520_CR81","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s13760-013-0179-5","volume":"113","author":"GS Duran","year":"2013","unstructured":"Duran GS, Uzunhan TA, Ekici B et al (2013) Severe scoliosis in a patient with COLQ mutation and congenital myasthenic syndrome: a clue for diagnosis. Acta Neurol Belg 113:531\u2013532","journal-title":"Acta Neurol Belg"},{"key":"7520_CR82","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1212\/01.wnl.0000167132.35865.31","volume":"65","author":"M Bestue-Cardiel","year":"2005","unstructured":"Bestue-Cardiel M, de Cabez\u00f3n-Alvarez a S\u00e1enz, Capablo-Liesa JL et al (2005) Congenital endplate acetylcholinesterase deficiency responsive to ephedrine. Neurology 65:144\u2013146","journal-title":"Neurology"},{"key":"7520_CR83","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1242\/jcs.092361","volume":"125","author":"K-R Choi","year":"2012","unstructured":"Choi K-R, Berrera M, Reischl M et al (2012) Rapsyn mediates subsynaptic anchoring of PKA type I and stabilisation of acetylcholine receptor in vivo. J Cell Sci 125:714\u2013723","journal-title":"J Cell Sci"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-014-7520-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-014-7520-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-014-7520-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T11:27:34Z","timestamp":1650454054000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-014-7520-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,11]]},"references-count":83,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["7520"],"URL":"https:\/\/doi.org\/10.1007\/s00415-014-7520-7","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,11]]}}}